Overview
MicroRNAs (miRNAs) are small, endogenous non-coding RNA molecules approximately 21-23 nucleotides in length. First discovered in 1993, these molecules have since been recognized as crucial regulators of gene expression in plants, animals, and some viruses. miRNAs typically bind to complementary sequences in the 3' untranslated regions of target messenger RNAs (mRNAs), leading to translational repression or mRNA degradation. In humans, miRNAs are estimated to regulate the expression of more than 60% of protein-coding genes. Over 2,000 miRNAs have been identified in the human genome, each potentially regulating hundreds of target genes. This extensive regulatory network makes miRNAs essential for numerous biological processes including development, differentiation, proliferation, and apoptosis.
Key Features
miRNAs exhibit several distinctive characteristics that make them powerful regulators of gene expression. Their small size allows them to target multiple mRNAs, enabling coordinated regulation of entire gene networks. Most miRNAs are highly conserved across species, suggesting their fundamental biological importance. Unlike other RNA molecules, miRNAs are processed from hairpin-shaped precursors by the enzymes Drosha and Dicer. Another key feature is their tissue-specific and developmentally regulated expression patterns. Some miRNAs are expressed ubiquitously, while others show highly restricted expression in specific cell types or developmental stages. This specificity makes them valuable biomarkers for various diseases. Additionally, miRNAs are remarkably stable in biological fluids, which has led to their exploration as non-invasive diagnostic markers.
Application Areas
In biomedical research, miRNAs are extensively studied for their roles in disease pathogenesis, particularly in cancer where they can function as oncogenes or tumor suppressors. miRNA profiling has become a valuable tool for disease classification, prognosis prediction, and treatment response monitoring. Several miRNA-based diagnostic tests have entered clinical use, including tests for certain cancers and cardiovascular diseases. Therapeutic applications of miRNAs are an active area of development, with miRNA mimics and inhibitors being investigated as potential treatments for various conditions. In agriculture, miRNA technology is being explored for crop improvement and pest control. Pharmaceutical companies are also investigating miRNAs as drug targets and as novel therapeutic agents themselves.
Precautions
When working with miRNAs, several precautions should be observed. Due to their small size and single-stranded nature, miRNAs are susceptible to degradation by RNases. Proper handling techniques including the use of RNase-free reagents and equipment are essential. Samples should typically be stored at -80°C for long-term preservation. Experimental design considerations are also important. The high degree of sequence similarity among miRNA family members can lead to cross-reactivity in detection methods. Appropriate controls should always be included in experiments. For therapeutic applications, careful consideration must be given to delivery methods and potential off-target effects due to the pleiotropic nature of miRNA regulation.
B2B Procurement Guide
For B2B buyers, several factors should be considered when procuring miRNA-related products and services. For research applications, verify the source organism and whether the product includes sequence validation data. Consider whether you need synthetic miRNAs, detection kits, profiling services, or bioinformatics analysis tools. For therapeutic development, assess the supplier's expertise in large-scale miRNA production and modification technologies. Pricing varies significantly based on quantity, purity, and modification level. Bulk purchases of commonly used research miRNAs may qualify for volume discounts. Lead times can be substantial for custom sequences, so plan accordingly. Always request certificates of analysis and inquire about the supplier's quality control procedures.
Related Manufacturers
- 主营：生物dna、dna病毒、dna回收、植物dna、dna产物、基因组dna、小提试剂盒、提取试剂盒、两步法细菌、离心柱式血液、酵母质粒提取、蛋白浓度测定、细胞增殖检测
- 主营：试剂盒、ELISA试剂盒
- 主营：蛋白酶、试剂盒、al缓冲液、pb缓冲液、eb缓冲液、一级代理、过滤漏斗、载物夹片、中国代理、尼龙过滤膜、核糖核酸酶、不锈钢过滤器、真空驱动装置、尾气检测滤膜、清洁度检测滤膜
- 主营：小鼠脾、besc20035、细胞系、人皮肤、试剂盒、兔结肠、兔膀胱、猪子宫、人胶质、猪骨髓、聚合酶、兔食管、兔胰腺、猪心肌、猪淋巴、bes2016dp、兔气管、兔子宫、besc20114、besc20110、核苷酸、besc20301、兔尿道、兔真皮、兔气道
- 主营：密理博滤膜、路明克斯luminex、默克纯水耗材、安捷伦衬管进样针、OXoid奥克欧德、thermo赛默飞分析耗材、琼脂糖凝胶、agilent安捷伦、氘灯、038141赛默飞进样瓶
- 主营：单细胞测序保存液、单细胞测序、空间转录组测序、转录组
- 主营：科研试剂、高效试剂
- 主营：有机小分子、共价抑制剂、多肽
- 主营：原代细胞、ELISA试剂盒、ELISA检测试剂盒、重组蛋白、天然蛋白、活性蛋白、基础培养基、完全培养基、抗体、标记抗体、人检测试剂盒、大鼠检测试剂盒、标记细胞、永生化细胞
- 主营：试剂、耗材、仪器、转染试剂、实验耗材、origene蛋白、takara试剂、CST抗体、abcam抗体、permagen磁力、polyplus转染、AcceGen细胞、qiagen试剂盒、zymo试剂盒、goldbio荧光素、Toxin肠毒素、速溶颗粒、DMEM培养基、胎牛血清、alzet渗透泵、伊莱瑞特、millipore、EZB试剂盒、细胞核悬液制备试剂盒、解离试剂盒
- 主营：ATCC细胞系、原代细胞、原代永生化
- 主营：酶cγ链、α2巨球、素d合成、纤连蛋白、抗组蛋白、肌醇抗体、蛋白样环、敏感蛋白、牛骨钙素、蛋白重链、金属肽酶、乳球蛋白、钩端螺旋、蛋白激酶、高血糖素、钙调蛋白、小鼠α1抗、ELISA试剂盒、pcr检测试剂、生化检测试剂
- 主营：抗体、感受态、培养基、试剂盒、层析柱、填料、生物试剂、化学试剂
- 主营：白细胞介素、生物试剂、甲状腺素、活性氧簇、促甲状腺激素、孕酮、促黄体生成素、心肌肌钙蛋白、检测试剂盒、植物试剂盒、试剂盒、实验室试剂、Elisa、定量分析、定性分析、酶联免疫试剂盒、科研试剂盒、免费代测
- 主营：RNA提取、DNA提取、qPCR